AlphaGenome 2: Deciphering how cells read DNA to better understand disease
What happened
AlphaGenome 2 is a new DNA sequence model that predicts how genetic variants affect gene expression in specific human cell types and states. It builds on the earlier AlphaGenome by using a conditional architecture that takes a DNA sequence and a biological condition as inputs, allowing it to model subtle differences between closely related cell types. Trained on over 100 million single‑cell profiles from 68 tissues, it can identify nearly twice as many variant‑driven expression changes as its predecessor. The model is available for non‑commercial research via an API and in private preview for commercial use.
Why it matters
By providing more accurate predictions of variant effects in disease‑relevant cells, researchers can better understand the cellular drivers of disease and prioritize experiments. This could accelerate discoveries in rare diseases and complex traits.
Reality check
An automated, sceptical read of the sourceIncremental. The update improves predictive performance and adds conditional modeling, but it is an evolution of an existing platform rather than a completely new paradigm.
Is this a big deal?
Get stories like this every morning
The day's AI news in plain English, in your inbox at 8:30 IST. Free.
More from Google
Google Search gets a major upgrade with Gemini 4 HydrogenGoogle · 12 Nov 2026Introducing Gemini 4 HydrogenGoogle · 12 Nov 2026Gemini 4 HydrogenGoogle · 12 Nov 2026Gemini Decisions API: Fast, calibrated multimodal decisionsGoogle · 11 Nov 2026Try Tabletop: Customizable, collaborative spaces for groups to plan, play and do more together.Google · 11 Nov 2026This page was collected from deepmind.google and summarised automatically by AIPulsee's pipeline. See how it runs.